business news in context, analysis with attitude

The Miami Herald reports that faced with a shortage of prescription medicines, Canadian pharmacies are now sourcing these products from other countries, including Australia, Chile, Israel, New Zealand and the United Kingdom.

The shortage is happening in part because so many medicines are being shipped to the US because they are cheaper than equivalent items would cost here; it also is occurring because US pharmaceutical companies, fed up with the practice called “reimportation,” are slowing shipments of products to Canada.

Ironically, of course, US regulators and drug companies have cast doubt on the efficacy of medicines imported from Canada because such products are not subjected to the same scrutiny as US drugs. This argument is likely to gain even greater currency if it can be proven that prescriptions being shipped to the US from Canada actually originated in, say, the Fiji Islands.
KC's View:
Lately, the US Food and Drug Administration (FDA) is backing off its objections to reimportation at least for the short term, and the US Congress is considering legislation that would make reimportation legal.

But this would appear to be a wrinkle that could cause some renewed concerns.